24/7 Market News Snapshot 25 June, 2025 – Femasys Inc. Common Stock (NASDAQ:FEMY)

DENVER, Colo., 25 June, 2025 (www.247marketnews.com) – (NASDAQ:FEMY) are discussed in this article.
Femasys Inc. (NASDAQ:FEMY) has made significant strides recently, both in its stock performance and groundbreaking advancements in women’s health. Opening at $0.90, FEMY shares experienced a notable increase, currently trading around $1.028, which reflects a robust upswing of approximately 16.16% from the previous session’s close of $0.885. This surge has been bolstered by a trading volume of 1.31 million shares, indicating heightened investor interest and market activity. As traders assess the stock’s technical indicators, a careful eye should be kept on support levels near $1.00 and resistance points around $1.10, setting the stage for future price movements that may capitalize on this bullish momentum.

In parallel, Femasys has achieved a landmark CE Mark certification for its FemBloc® System, the world’s first non-surgical permanent birth control solution utilizing a unique blended polymer system. This milestone, awarded after an extensive review process by the European Medicines Agency and a Notified Body, signifies a comprehensive approval for the FemBloc product line, inclusive of both the delivery system and the blended polymer component. With initial availability slated for Spain, Femasys plans to establish strategic partnerships to effectively launch its innovative solution across select markets in the European Economic Area.

CEO Kathy Lee-Sepsick expressed pride in this achievement, noting that the FemBloc System represents a safer alternative to traditional surgical sterilization—offering women an effective option without the associated risks of anesthesia and recovery. As the company continues its pivotal trial for FDA approval in the U.S., Femasys remains committed to transforming women’s reproductive health by addressing unmet needs and enhancing the overall quality of care in this crucial sector.

Related news for (FEMY)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.